DCF — MERCY MEDICAL CENTER-CENTERVILLE
Enterprise Value: $-97.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-97.2M
Enterprise Value
$-30.1M
PV of Cash Flows
$-67.1M
PV of Terminal Value
$-108.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $41.6M | $-6.4M | -15.0% | $-8.2M | $-7.4M |
| Year 2 | $42.9M | $-6.2M | -14.0% | $-8.0M | $-6.6M |
| Year 3 | $44.2M | $-5.9M | -13.0% | $-7.8M | $-5.9M |
| Year 4 | $45.5M | $-5.9M | -13.0% | $-7.8M | $-5.3M |
| Year 5 | $46.9M | $-5.9M | -13.0% | $-7.9M | $-4.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-97.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$40.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1589811253369954
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5